Skip to content

TONIX PHARMACEUTICALS HOLDING CORP.

TNXP

CIK 0001430306

← back to feed
Revenue (TTM)
$14.6M
+29.8% YoY Q1 May 2026
Net Income (TTM)
−$117.31M
+4.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$13.22
+91.7% YoY Q1 May 2026
Gross Margin
50.9%
Q1 May 2026
Operating Margin
-815.0%
Q1 May 2026
Net Margin
-803.7%
Q1 May 2026
Free Cash Flow (TTM)
−$114.99M
Q1 May 2026
Cash
$185.47M
Q1 May 2026
Total Debt
$7.49M
Q1 May 2026
Shares Outstanding
15.94M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings